Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL259P is a pseudogene in the human genome derived from the 7SL RNA gene (which codes for the RNA component of signal recognition particle, SRP). While 7SL RNA is essential for protein translocation, RN7SL259P is one of many dispersed, truncated, and nonfunctional copies known as pseudogenes. These arise from the integration of reverse-transcribed 7SL RNA fragments into new genomic loci, leading to sequences that cannot produce functional RNA nor participate in physiological processes. Only a few 7SL-related loci in humans remain functional; most are pseudogenes such as RN7SL259P and have no protein, receptor, or enzymatic function
None (not a drug target, no mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 259, pseudogene (RN7SL259P).